- Published on
Surgery - Varicose Veins
Introduction
veins that have gotten longer, wider, and more twisted; these are typically the lower limbs' superficial veins. These smaller superficial venous telangiectasias and varicosities are referred to as thread veins, spider veins, or reticular veins.
Etiology
Primary: As a result of decreased elasticity, gradual dilatation, and valvular incompetence brought on by a hereditary or developmental weakening of the vein wall.
Klippel-Trenaunay syndrome (port wine stains, varicose veins, and related hypertrophic limb tissue) and Parkes Weber syndrome (like KT, but with arteriovenous fistulas) are two congenital diseases linked to varicose veins.
Secondary: Obstacles to venous outflow include ascites, lymphadenopathy, ovarian cysts, pregnancy, pelvic cancer, and retroperitoneal fibrosis.
Damage to valves: After deep vein thrombosis (DVT). Arteriovenous fistula: high flow rate.
Epidemiology
Common, rising with age; prevalence: 10-15% for men and 20-25% for women in adulthood.
History
The patient may express dissatisfaction with their outward look or report experiencing symptoms like leg pain that worsens at the end of the day or after standing for extended periods of time; swelling, itching, or consequences including ulceration, bleeding, or infection. Ask about predisposing factors, vascular risk factors, and prior history of DVT.
Examination
Examine the venous distribution, skin alterations (such as varicose eczema, lipodermatosclerosis, oedema, atrophie blanche, or ulceration) while the patient is standing.
Palpation: Incompetent perforators' sites, the facial deformities along the dilated veins, may be felt.One could feel a cough impulse across the SFJ. The tap test is a procedure whereby an impulse, which is typically absent due to competent valves, is felt distally along the vein after tapping over the SFJ. Foot pulses should be recorded if they are present. An AV fistula is indicated by the palpation of a thrill or the auscultation of a bruit.
Trendelenburg test: Capable of pinpointing valvular incompetence locations. The leg is lifted and the veins are emptied while the patient is supine. The SFJ is compressed using a hand or tourniquet. The leg is positioned dependently, and either before or after the tourniquet or hand is released, the veins are seen to be filling.
Hand Held Doppler: Capable of displaying the valvular incompetence location.
Examining the pelvis or the rectum may be necessary if secondary reasons are thought to be present.
Pathogenesis
Varicose vein etiology theories include primary valvular incompetence and the development of venous wall weakness as a result of anomalies in collagen and elastin, culminating in advanced stages of tunica media fibrosis. Hormonal fluctuations and venous hypertension are two more reasons that are implicated.
Investigations
Visualization: Duplex ultrasound: Identifies reflux or incompetence locations. Moreover, to rule out DVT (essential if surgery is being considered). MR venography: reserved for complicated situations.
Management
Conservative: Exercise recommendations (which enhance the calf muscle pump) and elevating the legs when at rest. Class II support stockings can help decrease edema and facilitate venous return.
Surgical procedures include SFJ ligation, lengthy saphenous vein stripping up to the knee, and varicosity avulsion using tiny stab incisions. To protect the sural nerve, the short saphenous vein is ligated rather than stripped.
Endovenous operations are becoming more and more common and can be carried out under local anesthesia. The long saphenous vein is ablateted using endovenous laser treatment (EVLT) after a tumescent local anesthetic is injected around the vein under ultrasound supervision.
Thermal damage and ablation are also involved in radiofrequency ablation. With foam sclerotherapy, endothelial damage, inflammation, and subsequent vein fibrosis are caused by injecting sclerosing foam along the vein with the help of ultrasound guidance. The legs are wrapped following all treatments, and early mobilization is advised.
Using laser sclerotherapy or microinjection for reticular veins and venous telangiectasia.
Complications
eczema, lipodermatosclerosis, venous ulcers, superficial thrombophlebitis, and venous pigmentation.
Treatment outcome: Recurrence. Intravenous therapy: Burns to the skin, nerve damage, bruises, emboli, and DVT. Surgical complications: bleeding, infection, nerve damage, or paraesthesia (up to 6%).
Prognosis
generally progressing slowly. After surgery, recurrence rates can reach 40%.
Introduction
veins that have gotten longer, wider, and more twisted; these are typically the lower limbs' superficial veins. These smaller superficial venous telangiectasias and varicosities are referred to as thread veins, spider veins, or reticular veins.
Etiology
Primary: As a result of decreased elasticity, gradual dilatation, and valvular incompetence brought on by a hereditary or developmental weakening of the vein wall.
Klippel-Trenaunay syndrome (port wine stains, varicose veins, and related hypertrophic limb tissue) and Parkes Weber syndrome (like KT, but with arteriovenous fistulas) are two congenital diseases linked to varicose veins.
Secondary: Obstacles to venous outflow include ascites, lymphadenopathy, ovarian cysts, pregnancy, pelvic cancer, and retroperitoneal fibrosis.
Damage to valves: After deep vein thrombosis (DVT). Arteriovenous fistula: high flow rate.
Epidemiology
Common, rising with age; prevalence: 10-15% for men and 20-25% for women in adulthood.
History
The patient may express dissatisfaction with their outward look or report experiencing symptoms like leg pain that worsens at the end of the day or after standing for extended periods of time; swelling, itching, or consequences including ulceration, bleeding, or infection. Ask about predisposing factors, vascular risk factors, and prior history of DVT.
Examination
Examine the venous distribution, skin alterations (such as varicose eczema, lipodermatosclerosis, oedema, atrophie blanche, or ulceration) while the patient is standing.
Palpation: Incompetent perforators' sites, the facial deformities along the dilated veins, may be felt.One could feel a cough impulse across the SFJ. The tap test is a procedure whereby an impulse, which is typically absent due to competent valves, is felt distally along the vein after tapping over the SFJ. Foot pulses should be recorded if they are present. An AV fistula is indicated by the palpation of a thrill or the auscultation of a bruit.
Trendelenburg test: Capable of pinpointing valvular incompetence locations. The leg is lifted and the veins are emptied while the patient is supine. The SFJ is compressed using a hand or tourniquet. The leg is positioned dependently, and either before or after the tourniquet or hand is released, the veins are seen to be filling.
Hand Held Doppler: Capable of displaying the valvular incompetence location.
Examining the pelvis or the rectum may be necessary if secondary reasons are thought to be present.
Pathogenesis
Varicose vein etiology theories include primary valvular incompetence and the development of venous wall weakness as a result of anomalies in collagen and elastin, culminating in advanced stages of tunica media fibrosis. Hormonal fluctuations and venous hypertension are two more reasons that are implicated.
Investigations
Visualization: Duplex ultrasound: Identifies reflux or incompetence locations. Moreover, to rule out DVT (essential if surgery is being considered). MR venography: reserved for complicated situations.
Management
Conservative: Exercise recommendations (which enhance the calf muscle pump) and elevating the legs when at rest. Class II support stockings can help decrease edema and facilitate venous return.
Surgical procedures include SFJ ligation, lengthy saphenous vein stripping up to the knee, and varicosity avulsion using tiny stab incisions. To protect the sural nerve, the short saphenous vein is ligated rather than stripped.
Endovenous operations are becoming more and more common and can be carried out under local anesthesia. The long saphenous vein is ablateted using endovenous laser treatment (EVLT) after a tumescent local anesthetic is injected around the vein under ultrasound supervision.
Thermal damage and ablation are also involved in radiofrequency ablation. With foam sclerotherapy, endothelial damage, inflammation, and subsequent vein fibrosis are caused by injecting sclerosing foam along the vein with the help of ultrasound guidance. The legs are wrapped following all treatments, and early mobilization is advised.
Using laser sclerotherapy or microinjection for reticular veins and venous telangiectasia.
Complications
eczema, lipodermatosclerosis, venous ulcers, superficial thrombophlebitis, and venous pigmentation.
Treatment outcome: Recurrence. Intravenous therapy: Burns to the skin, nerve damage, bruises, emboli, and DVT. Surgical complications: bleeding, infection, nerve damage, or paraesthesia (up to 6%).
Prognosis
generally progressing slowly. After surgery, recurrence rates can reach 40%.
- Published on
Clinical Procedures - Consent
Overview
A person's consent is their permission to be subjected to anything, including medical examinations and surgical operations. It is illegal to perform an act on a competent adult without that adult's consent.
Ability • The patient must be able to comprehend the nature of the procedure and the potential repercussions of making or not making a decision. It is presumed that all adults possess capacity unless proven differently:
It is crucial to remember that "capacity" only pertains to the particular choice that is being discussed.
Evaluating ability
The patient needs to be able to: • Recognize the knowledge and its implications
• Preserve the data; • Consider the data while making decisions; • Share their conclusion.
A patient who is incapable
• It is important to fully explain your reasoning for thinking a patient lacks the capacity to make a certain decision.
• A patient may have extreme confusion, which could render them momentarily debilitated. In these situations, treatment may only be administered if it cannot be reasonably postponed until the impairment is remedied. If so, the patient's best interests must be taken into consideration while choosing a course of therapy.
Voluntary Consent: Patients should be seen alone when there is a chance of external influence in order for them to form their own opinion. Consent is only legitimate if it is provided voluntarily, free from coercion from friends, family, or medical professionals.
In order for patients to make an informed choice, they must be given enough information.
Information needs to be provided about: • What the process involves and why it is being done; • Any accessible alternatives.
• Serious dangers:
• This encompasses not only risks that are judged serious by an authoritative body of medical opinion (the Bolam test), but also any "significant risk which would affect the judgement of a reasonable patient."
If you don't communicate these hazards, you could be found negligent.
• Patients who deny information about a surgery should have this carefully documented and given the chance to discuss it at a later time. • Any other operations that might be required under the same anesthesia should be discussed during the first consent.
Consent Documents
• Consent is invalid regardless of the presence of a consent form if it is not voluntary, there is insufficient information, or the patient lacks ability. Written consent is proof that consent has been requested but does not validate its validity.
• Written consent is required for some procedures (as listed in the Mental Health Act and the Human Fertilization and Embryology Act). • Oral or non-verbal consent may also be accepted.
Who Has to Request Consent?
• The expert requesting consent must, at the very least, be knowledgeable enough to comprehend and describe the procedure, its indications, and any associated risks.
It is your duty to approach colleagues for assistance if you are asked to give consent for a procedure but are unsure about it; failing to do so could result in your consent being deemed invalid.
Refusing to Give Consent
Even if a patient's refusal will result in their death or the death of their unborn child, an adult with capacity who refuses to consent to a procedure must be respected (with the exception of certain situations listed in the Mental Health Act). In these situations, a thorough assessment of the patient's competence is required. The same is true if the patient withdraws consent at any point while they are still capable.
• In certain situations, it could be challenging to determine capacity because, for example, a patient experiencing discomfort could momentarily lose capacity during a procedure.
Advance Refusal: • It is applicable when the patient lacks capacity • It is valid when made during a period when the patient is competent and sufficiently informed • Failure to abide by the refusal may result in legal action • If there is any uncertainty as to its legitimacy, the courts must be contacted.
Adults Without Capacity
• May be transient, ongoing, or fluctuating; ► In the absence of a valid Lasting Power of Attorney, no one may provide consent on behalf of an incompetent adult; ► Patients must be treated in their best interests (not just medical interests), taking into account their psychological, spiritual, and economical well-being.
• When there is uncertainty regarding the patient's best interests or capacity, the High Court may render a decision. • When the patient has expressed previously that they should not be involved, those closest to them should be involved; independent patient advocacy services are available for consultation in this situation.
• Temporary incapacity: when competent, get consent; if not, act in the person's best interests.
Lasting Power of Attorney (Mental Capacity Act of 2005)
• A document made by someone (the "donor") granting permission to a named person or people (the "donees") to consent to research or treatment (among other things).
• Needs to be registered;
• Only good while the sufferer is incapable of
• The donee must be expressly given permission to decide on their own welfare and medical care:
• unless otherwise indicated, do not include choices for life-sustaining medical care.
Patients under the age of eighteen (16–17):
• If competent, they may accept or reject an intervention; if not, someone with parental responsibility may give consent.
Less than 16: Gillick 1 Competence.
If a kid under the age of 16 is able to comprehend the entire scope of an intervention, they may provide their consent to treatment. This may apply to certain therapies but not others.
• Parental consent is not necessary if a child is Gillick competent, but it is a good idea to encourage a child to tell their parents unless doing so would be against their best interests.
deciding factors: younger than 18
• Refusal should take into account the person's wellbeing overall; it can be overruled by the courts or by someone with parental responsibility. In an emergency, it is acceptable to preserve life when a person with parental responsibility is unreachable or refuses consent for life-saving treatment that seems to be in the best interests of the child. This may involve sharing information that the child does not wish to share; necessary if refusal puts the child at serious risk.
Overview
A person's consent is their permission to be subjected to anything, including medical examinations and surgical operations. It is illegal to perform an act on a competent adult without that adult's consent.
Ability • The patient must be able to comprehend the nature of the procedure and the potential repercussions of making or not making a decision. It is presumed that all adults possess capacity unless proven differently:
It is crucial to remember that "capacity" only pertains to the particular choice that is being discussed.
Evaluating ability
The patient needs to be able to: • Recognize the knowledge and its implications
• Preserve the data; • Consider the data while making decisions; • Share their conclusion.
A patient who is incapable
• It is important to fully explain your reasoning for thinking a patient lacks the capacity to make a certain decision.
• A patient may have extreme confusion, which could render them momentarily debilitated. In these situations, treatment may only be administered if it cannot be reasonably postponed until the impairment is remedied. If so, the patient's best interests must be taken into consideration while choosing a course of therapy.
Voluntary Consent: Patients should be seen alone when there is a chance of external influence in order for them to form their own opinion. Consent is only legitimate if it is provided voluntarily, free from coercion from friends, family, or medical professionals.
In order for patients to make an informed choice, they must be given enough information.
Information needs to be provided about: • What the process involves and why it is being done; • Any accessible alternatives.
• Serious dangers:
• This encompasses not only risks that are judged serious by an authoritative body of medical opinion (the Bolam test), but also any "significant risk which would affect the judgement of a reasonable patient."
If you don't communicate these hazards, you could be found negligent.
• Patients who deny information about a surgery should have this carefully documented and given the chance to discuss it at a later time. • Any other operations that might be required under the same anesthesia should be discussed during the first consent.
Consent Documents
• Consent is invalid regardless of the presence of a consent form if it is not voluntary, there is insufficient information, or the patient lacks ability. Written consent is proof that consent has been requested but does not validate its validity.
• Written consent is required for some procedures (as listed in the Mental Health Act and the Human Fertilization and Embryology Act). • Oral or non-verbal consent may also be accepted.
Who Has to Request Consent?
• The expert requesting consent must, at the very least, be knowledgeable enough to comprehend and describe the procedure, its indications, and any associated risks.
It is your duty to approach colleagues for assistance if you are asked to give consent for a procedure but are unsure about it; failing to do so could result in your consent being deemed invalid.
Refusing to Give Consent
Even if a patient's refusal will result in their death or the death of their unborn child, an adult with capacity who refuses to consent to a procedure must be respected (with the exception of certain situations listed in the Mental Health Act). In these situations, a thorough assessment of the patient's competence is required. The same is true if the patient withdraws consent at any point while they are still capable.
• In certain situations, it could be challenging to determine capacity because, for example, a patient experiencing discomfort could momentarily lose capacity during a procedure.
Advance Refusal: • It is applicable when the patient lacks capacity • It is valid when made during a period when the patient is competent and sufficiently informed • Failure to abide by the refusal may result in legal action • If there is any uncertainty as to its legitimacy, the courts must be contacted.
Adults Without Capacity
• May be transient, ongoing, or fluctuating; ► In the absence of a valid Lasting Power of Attorney, no one may provide consent on behalf of an incompetent adult; ► Patients must be treated in their best interests (not just medical interests), taking into account their psychological, spiritual, and economical well-being.
• When there is uncertainty regarding the patient's best interests or capacity, the High Court may render a decision. • When the patient has expressed previously that they should not be involved, those closest to them should be involved; independent patient advocacy services are available for consultation in this situation.
• Temporary incapacity: when competent, get consent; if not, act in the person's best interests.
Lasting Power of Attorney (Mental Capacity Act of 2005)
• A document made by someone (the "donor") granting permission to a named person or people (the "donees") to consent to research or treatment (among other things).
• Needs to be registered;
• Only good while the sufferer is incapable of
• The donee must be expressly given permission to decide on their own welfare and medical care:
• unless otherwise indicated, do not include choices for life-sustaining medical care.
Patients under the age of eighteen (16–17):
• If competent, they may accept or reject an intervention; if not, someone with parental responsibility may give consent.
Less than 16: Gillick 1 Competence.
If a kid under the age of 16 is able to comprehend the entire scope of an intervention, they may provide their consent to treatment. This may apply to certain therapies but not others.
• Parental consent is not necessary if a child is Gillick competent, but it is a good idea to encourage a child to tell their parents unless doing so would be against their best interests.
deciding factors: younger than 18
• Refusal should take into account the person's wellbeing overall; it can be overruled by the courts or by someone with parental responsibility. In an emergency, it is acceptable to preserve life when a person with parental responsibility is unreachable or refuses consent for life-saving treatment that seems to be in the best interests of the child. This may involve sharing information that the child does not wish to share; necessary if refusal puts the child at serious risk.
- Published on
Clinical Procedures - Aseptic Non-Touch Technique
The highest level of asepsis, designed to minimize or completely remove the chance of contamination is known as 'aseptic non-touch technique (ANTT) Although local practices and rules may differ, the principles behind it are universal.
When to use ANTT
◦ Insertion, repositioning, or dressing invasive devices such as catheters, drains, and intravenous lines
◦ Dressing wounds healing by primary intention (surgical wounds, burns)
◦ Suturing
◦ When sterile body areas are to be entered
◦ If there is tracking to deeper areas or the patient is immunocompromised.
Two-person technique
◦ An assistant can be very helpful in maintaining the position of the patient, opening packs, and decanting solutions for the person performing the procedure
◦ The 'clean practitioner' must wear the sterile glove and open the first pack to establish a sterile field. The second ('dirty) practitioner can then open all the other equipment and drop onto the sterile field.
◦ Interruptions
◦ If the sterile procedure is interrupted for more than 30 minutes, new sterile packs should be opened.
Clean Technique
◦ This is a modified aseptic technique, aiming to prevent the introduction or spread of micro-organisms and to prevent cross-infection to patients and staff. This is used when true asepsis is not required (e.g. when dealing with contaminated sites or when removing drains and catheters)
◦ Sterile equipment is not always used
◦ 'Clean technique allows the use of tap water, non-sterile gloves, multi-pack dressings, and multi-use containers of creams and ointments.
When to use clean technique
◦ Removing sutures, drains, urethral catheters
◦ Endotracheal suction, management of tracheostomy site
◦ Management of enteral feeding lines
◦ Care of stomas
Instillation of eye-drops.
You should always consider the sterility of the items to be touched before you begin each procedure. If some or all items need to remain sterile, an aseptic technique should be used.
Aseptic Non- Touch Technique Procedure
Before
◦ Wash hands with soap and water or alcohol gel
◦ Put on disposable apron and any other protective items
◦ Clean trolley/tray with wipes and dry with a paper towel
◦ Gather equipment and put on the lower shelf of the trolley
◦ Take trolley/tray to the patient.
During
◦ Wash hands with alcohol gel
◦ Remove sterile pack outer packaging and slide the contents on to the top shelf of the trolley or onto the tray, taking care not to touch the sterile pack
◦ Open the dressing pack using only the corners of the paper, taking care not to touch any of the sterile equipment
◦ Place any other required items on the sterile field ensuring that the outer packaging does not come into contact with the sterile field
◦ Put a pair of non-sterile gloves on to remove any dressings on the patient and ensure that they are positioned appropriately
◦ Discard gloves and wash hands
◦ Put sterile gloves on.
After
◦ Dispose of contaminated equipment in the rubbish bag from the dressing pack. Dispose of all packaging
◦ Dispose of aprons and gloves in the appropriate waste as per local policy
◦ Wash hands
Clean the trolley with detergent wipes and dry with a paper towel.
The highest level of asepsis, designed to minimize or completely remove the chance of contamination is known as 'aseptic non-touch technique (ANTT) Although local practices and rules may differ, the principles behind it are universal.
When to use ANTT
◦ Insertion, repositioning, or dressing invasive devices such as catheters, drains, and intravenous lines
◦ Dressing wounds healing by primary intention (surgical wounds, burns)
◦ Suturing
◦ When sterile body areas are to be entered
◦ If there is tracking to deeper areas or the patient is immunocompromised.
Two-person technique
◦ An assistant can be very helpful in maintaining the position of the patient, opening packs, and decanting solutions for the person performing the procedure
◦ The 'clean practitioner' must wear the sterile glove and open the first pack to establish a sterile field. The second ('dirty) practitioner can then open all the other equipment and drop onto the sterile field.
◦ Interruptions
◦ If the sterile procedure is interrupted for more than 30 minutes, new sterile packs should be opened.
Clean Technique
◦ This is a modified aseptic technique, aiming to prevent the introduction or spread of micro-organisms and to prevent cross-infection to patients and staff. This is used when true asepsis is not required (e.g. when dealing with contaminated sites or when removing drains and catheters)
◦ Sterile equipment is not always used
◦ 'Clean technique allows the use of tap water, non-sterile gloves, multi-pack dressings, and multi-use containers of creams and ointments.
When to use clean technique
◦ Removing sutures, drains, urethral catheters
◦ Endotracheal suction, management of tracheostomy site
◦ Management of enteral feeding lines
◦ Care of stomas
Instillation of eye-drops.
You should always consider the sterility of the items to be touched before you begin each procedure. If some or all items need to remain sterile, an aseptic technique should be used.
Aseptic Non- Touch Technique Procedure
Before
◦ Wash hands with soap and water or alcohol gel
◦ Put on disposable apron and any other protective items
◦ Clean trolley/tray with wipes and dry with a paper towel
◦ Gather equipment and put on the lower shelf of the trolley
◦ Take trolley/tray to the patient.
During
◦ Wash hands with alcohol gel
◦ Remove sterile pack outer packaging and slide the contents on to the top shelf of the trolley or onto the tray, taking care not to touch the sterile pack
◦ Open the dressing pack using only the corners of the paper, taking care not to touch any of the sterile equipment
◦ Place any other required items on the sterile field ensuring that the outer packaging does not come into contact with the sterile field
◦ Put a pair of non-sterile gloves on to remove any dressings on the patient and ensure that they are positioned appropriately
◦ Discard gloves and wash hands
◦ Put sterile gloves on.
After
◦ Dispose of contaminated equipment in the rubbish bag from the dressing pack. Dispose of all packaging
◦ Dispose of aprons and gloves in the appropriate waste as per local policy
◦ Wash hands
Clean the trolley with detergent wipes and dry with a paper towel.
- Published on
Clinical Procedures – Hand Hygiene
When?
The WHO World Alliance for Patient Safety, in 2006, identified '5 moments' for hand hygiene. These are:
• Before patient contact:
• Before touching a patient, when approaching him/her
• Before an aseptic task
• After body fluid exposure risk:
• Immediately after exposure or potential exposure to body fluid (and after removing your gloves)
• After patient contact:
• After touching a patient and his/her immediate surroundings, when you leave the patient's side
• After contact with a patient's surroundings:
• After touching any object or furniture in the patient's immediate surrounding when leaving even if you haven't touched the patient.
Soap or Alcohol Gel?
Repeated washing with soap and water can cause skin dryness and can be time consuming. For these reasons, alcohol gel has become commonplace in clinical settings.
There are no hard and fast rules but:
• Alcohol gel should not be a substitute for soap and water your hands are visibly soiled or if you are undertaking an aseptic procedure
• Remember that alcohol gel is not effective against
Clostridium difficile.
Should visitors also be cleaning their hands?
There is little solid evidence that this is effective in reducing hospital infections. However, visitors are encouraged to clean their hands in most clinical areas, partly because it raises the public profile of the importance of hand hygiene.
Soap and Water Technique
• Adhere to 'bare below elbow' rule
• Wet hands with water
• Apply soap (from a dispenser) to cover all hand surfaces
• Ensure all 7 parts of the hands are thoroughly cleaned:
• Rub hands palm-to-palm
• Rub back of each hand with the palm of the other, fingers interlaced
• Rub hands palm-to-palm with fingers interlaced
• Lock hands together and rub backs of fingers against opposite palm
• Rub thumbs in rotational movement with opposite hand
• Rub tips of fingers into opposite palms
• Rub each wrist with opposite hand
• Hold hands under running water, rub vigorously to remove all suds
. Turn off taps using elbow
• Dry thoroughly with paper towel
• Dispose of paper towels in appropriate clinical bin (using foot pedal to open)
• DO NOT TOUCH any other objects until task is undertaken and completed.
Alcohol Gel Technique
Essentially the same technique as above but no need to rinse or dry with paper towel.
• Squirt small amount of gel onto centre of palm
• Ensure all 7 parts of the hands are thoroughly cleaned as above
• Allow 20-30 seconds for hands to dry, holding hands up
• Following disinfection, DO NOT TOUCH any other objects prior to commencing procedure.
When?
The WHO World Alliance for Patient Safety, in 2006, identified '5 moments' for hand hygiene. These are:
• Before patient contact:
• Before touching a patient, when approaching him/her
• Before an aseptic task
• After body fluid exposure risk:
• Immediately after exposure or potential exposure to body fluid (and after removing your gloves)
• After patient contact:
• After touching a patient and his/her immediate surroundings, when you leave the patient's side
• After contact with a patient's surroundings:
• After touching any object or furniture in the patient's immediate surrounding when leaving even if you haven't touched the patient.
Soap or Alcohol Gel?
Repeated washing with soap and water can cause skin dryness and can be time consuming. For these reasons, alcohol gel has become commonplace in clinical settings.
There are no hard and fast rules but:
• Alcohol gel should not be a substitute for soap and water your hands are visibly soiled or if you are undertaking an aseptic procedure
• Remember that alcohol gel is not effective against
Clostridium difficile.
Should visitors also be cleaning their hands?
There is little solid evidence that this is effective in reducing hospital infections. However, visitors are encouraged to clean their hands in most clinical areas, partly because it raises the public profile of the importance of hand hygiene.
Soap and Water Technique
• Adhere to 'bare below elbow' rule
• Wet hands with water
• Apply soap (from a dispenser) to cover all hand surfaces
• Ensure all 7 parts of the hands are thoroughly cleaned:
• Rub hands palm-to-palm
• Rub back of each hand with the palm of the other, fingers interlaced
• Rub hands palm-to-palm with fingers interlaced
• Lock hands together and rub backs of fingers against opposite palm
• Rub thumbs in rotational movement with opposite hand
• Rub tips of fingers into opposite palms
• Rub each wrist with opposite hand
• Hold hands under running water, rub vigorously to remove all suds
. Turn off taps using elbow
• Dry thoroughly with paper towel
• Dispose of paper towels in appropriate clinical bin (using foot pedal to open)
• DO NOT TOUCH any other objects until task is undertaken and completed.
Alcohol Gel Technique
Essentially the same technique as above but no need to rinse or dry with paper towel.
• Squirt small amount of gel onto centre of palm
• Ensure all 7 parts of the hands are thoroughly cleaned as above
• Allow 20-30 seconds for hands to dry, holding hands up
• Following disinfection, DO NOT TOUCH any other objects prior to commencing procedure.
- Published on
Clinical Procedures – Subcutaneous injection
Subcutaneous injections can be administered at essentially any site with adequate subcutaneous tissue. Usual sites are upper arms and the abdomen, particularly the periumbilical region.
Ensure that you comply with the local policy regarding drug administration. In hospital, two healthcare professionals should usually check and administer medication.
Equipment
• Appropriate syringe (dependent upon quantity of drug to be administered)
• 25G (orange) needle (usually)
• Prescribed drug
• Prescription chart
• Antiseptic swab
• Plaster.
Procedure
• Assess patient for drugs required (i.e. for pain relief, vomiting etc.)
• Refer to prescription chart, double-checking the appropriate drugs and dosage to be given:
• Always ensure you are fully aware of any possible side effects of any drugs you are due to administer
• Double-check the prescription chart for date and appropriate route for administration
• Check administration of previous dose not too soon after last dose?
• Ensure that the drug to be given is within its use-by date
• Check patient and chart for any evidence of allergies, or relevant drug reactions
• Always comply with the local hand-hygiene practices
• Once all above completed as per hospital policy, draw-up required drug and check appropriate needle size
• Complete appropriate documentation
Documentation
• Drugs should always be signed for as per local policy
• Signature and time should be clearly recorded
• Site drug administered
• Reason for drug administration, time given, and any impact on the patient should be recorded in the nursing notes
• Immediate vital signs should be recorded in notes
• Any causes for concern arising from administration of drugs should be clearly documented in the medical notes
• Signature, printed name, and contact details.
• Once checked by suitably qualified staff take drug and prescription chart to the patient
• Introduce yourself, confirm the patient's identity, explain the procedure, and obtain informed consent
• Check with patient: name and date of birth (if capable):
• If incapable, check name band with another healthcare professional
•© The patient may need to be assisted to change position, if unable to move themselves, and to enable access to an appropriate site
• Select appropriate site, and cleanse with the antiseptic wipe
• Grasp skin firmly between thumb and forefinger of your left hand
• Insert needle at 45° angle into the pinched skin, then release skin from your grip
• Draw syringe plunger back, checking for any blood. If none, inject drug slowly:
• D If any blood is noted on pulling the plunger back, withdraw and stop procedure provide reassurance and explanation to the patient
• Once the procedure is completed without complication, withdraw needle and discard into a sharps bin
• Monitor patient for any negative effects of the drug.
Subcutaneous injections can be administered at essentially any site with adequate subcutaneous tissue. Usual sites are upper arms and the abdomen, particularly the periumbilical region.
Ensure that you comply with the local policy regarding drug administration. In hospital, two healthcare professionals should usually check and administer medication.
Equipment
• Appropriate syringe (dependent upon quantity of drug to be administered)
• 25G (orange) needle (usually)
• Prescribed drug
• Prescription chart
• Antiseptic swab
• Plaster.
Procedure
• Assess patient for drugs required (i.e. for pain relief, vomiting etc.)
• Refer to prescription chart, double-checking the appropriate drugs and dosage to be given:
• Always ensure you are fully aware of any possible side effects of any drugs you are due to administer
• Double-check the prescription chart for date and appropriate route for administration
• Check administration of previous dose not too soon after last dose?
• Ensure that the drug to be given is within its use-by date
• Check patient and chart for any evidence of allergies, or relevant drug reactions
• Always comply with the local hand-hygiene practices
• Once all above completed as per hospital policy, draw-up required drug and check appropriate needle size
• Complete appropriate documentation
Documentation
• Drugs should always be signed for as per local policy
• Signature and time should be clearly recorded
• Site drug administered
• Reason for drug administration, time given, and any impact on the patient should be recorded in the nursing notes
• Immediate vital signs should be recorded in notes
• Any causes for concern arising from administration of drugs should be clearly documented in the medical notes
• Signature, printed name, and contact details.
• Once checked by suitably qualified staff take drug and prescription chart to the patient
• Introduce yourself, confirm the patient's identity, explain the procedure, and obtain informed consent
• Check with patient: name and date of birth (if capable):
• If incapable, check name band with another healthcare professional
•© The patient may need to be assisted to change position, if unable to move themselves, and to enable access to an appropriate site
• Select appropriate site, and cleanse with the antiseptic wipe
• Grasp skin firmly between thumb and forefinger of your left hand
• Insert needle at 45° angle into the pinched skin, then release skin from your grip
• Draw syringe plunger back, checking for any blood. If none, inject drug slowly:
• D If any blood is noted on pulling the plunger back, withdraw and stop procedure provide reassurance and explanation to the patient
• Once the procedure is completed without complication, withdraw needle and discard into a sharps bin
• Monitor patient for any negative effects of the drug.
- Published on
Clinical Procedures - Intramuscular Injection
Intramuscular injections can be administered at essentially any site with adequate muscle mass. Usual sites are deltoids and the gluteal region (upper, outer quadrant of buttock).
• Ensure that you comply with the local policy regarding drug administration. In hospital, two healthcare professionals should usually check and administer medication.
Equipment
• Appropriate syringe (dependent upon quantity of drug to be administered
• 25G (orange) needle (usually)
• Prescribed drug
• Prescription chart
• Antiseptic swab
• Plaster.
Procedure
• Assess patient for drugs required (i.e. for pain relief, vomiting etc.)
• Refer to prescription chart, double-checking the appropriate drugs and dosage to be given:
• D Always ensure you are fully aware of any possible side effects of any drugs you are due to administer
• Double-check the prescription chart for date and appropriate route for administration
• Check administration of previous dose not too soon after last dose?
• Ensure that the drug to be given is within its use-by §
• Check patient and chart for any evidence of allergies. relevant drug reactions
• Always comply with the local hand-hygiene practices
• Once all above completed as per hospital policy, draw-up required drug and check appropriate needle size
• Complete appropriate documentation
Documentation
• Drugs should always be signed for as per local policy
• Signature and time should be clearly recorded
• Site drug administered
• Reason for drug administration, time given, and any impact on the patient should be recorded in the nursing notes
• Immediate vital signs should be recorded in notes
• Any causes for concern arising from administration of drugs should be clearly documented in the medical notes
• Signature, printed name, and contact details.
• Once checked by suitably qualified staff take drug and prescription chart to the patient
• Introduce yourself, confirm the patient's identity, explain the procedure, and obtain informed consent
• Check with patient: name and date of birth (if capable):
• If incapable, check name band with another healthcare professional
• The patient may need to be assisted to change position, if unable to move themselves, and to enable access to an appropriate site
• Select appropriate site, and cleanse with the antiseptic wipe:
If injecting into the buttock, mark a spot at the upper, outer quadrant to avoid the sciatic nerve
•If using the deltoid muscle, feel the muscle mass and ensure there is enough muscle to take the needle
• Insert needle at 90° angle into the skin
• Draw syringe plunger back, checking for any blood. If none, inject drug slowly:
• D If any blood is noted on pulling the plunger back, withdraw and stop procedure provide reassurance and explanation to the patient
• Once the procedure is completed without complication, withdraw needle and discard into a sharps bin
• Monitor patient for any negative effects of the drug.
Intramuscular injections can be administered at essentially any site with adequate muscle mass. Usual sites are deltoids and the gluteal region (upper, outer quadrant of buttock).
• Ensure that you comply with the local policy regarding drug administration. In hospital, two healthcare professionals should usually check and administer medication.
Equipment
• Appropriate syringe (dependent upon quantity of drug to be administered
• 25G (orange) needle (usually)
• Prescribed drug
• Prescription chart
• Antiseptic swab
• Plaster.
Procedure
• Assess patient for drugs required (i.e. for pain relief, vomiting etc.)
• Refer to prescription chart, double-checking the appropriate drugs and dosage to be given:
• D Always ensure you are fully aware of any possible side effects of any drugs you are due to administer
• Double-check the prescription chart for date and appropriate route for administration
• Check administration of previous dose not too soon after last dose?
• Ensure that the drug to be given is within its use-by §
• Check patient and chart for any evidence of allergies. relevant drug reactions
• Always comply with the local hand-hygiene practices
• Once all above completed as per hospital policy, draw-up required drug and check appropriate needle size
• Complete appropriate documentation
Documentation
• Drugs should always be signed for as per local policy
• Signature and time should be clearly recorded
• Site drug administered
• Reason for drug administration, time given, and any impact on the patient should be recorded in the nursing notes
• Immediate vital signs should be recorded in notes
• Any causes for concern arising from administration of drugs should be clearly documented in the medical notes
• Signature, printed name, and contact details.
• Once checked by suitably qualified staff take drug and prescription chart to the patient
• Introduce yourself, confirm the patient's identity, explain the procedure, and obtain informed consent
• Check with patient: name and date of birth (if capable):
• If incapable, check name band with another healthcare professional
• The patient may need to be assisted to change position, if unable to move themselves, and to enable access to an appropriate site
• Select appropriate site, and cleanse with the antiseptic wipe:
If injecting into the buttock, mark a spot at the upper, outer quadrant to avoid the sciatic nerve
•If using the deltoid muscle, feel the muscle mass and ensure there is enough muscle to take the needle
• Insert needle at 90° angle into the skin
• Draw syringe plunger back, checking for any blood. If none, inject drug slowly:
• D If any blood is noted on pulling the plunger back, withdraw and stop procedure provide reassurance and explanation to the patient
• Once the procedure is completed without complication, withdraw needle and discard into a sharps bin
• Monitor patient for any negative effects of the drug.
- Published on
Surgery - Prostate Carcinoma
Introduction
a primary prostate gland malignant tumor. 95% of the cases are adenocarcinomas, which vary in their level of differentiation.
Risk Factors
The largest risk factor is age. Afro-Caribbean people are more likely than Caucasian people to present with an aggressive disease at a younger age. Geographic distribution: lower in the Far East and higher in North America and Europe. Gene implicated on chromosome 1 in family history. Dietary factors: Consumption of meat, alcohol, and high fat foods is linked to reduced soy intake.
Epidemiology
The second leading cause of cancer-related mortality in men. 50–70 instances per 100,000 year.
80% of males over 80 years old who have autopsies had microfoci related to malignancy.
History
frequently asymptomatic and found through PSA testing.
Obstruction of the lower urinary tract: nocturia, terminal dribbling, weak stream, hesitation, and frequency.
Metastatic spread: Spinal cord compression or discomfort in the bones as a result of metastases.
Anorexia, weight loss, and malaise are common signs of cancer.
Examination
Asymmetrical hard nodular prostate gland with lack of the midline sulcus was seen during a digital rectal examination.
Investigations
Blood: bone profile, PSA, LFT, U&E, and FBC.
Antigen specific to prostates: Age-related and non-specific values may be higher in cases of prostatitis, benign prostatic hyperplasia, or after catheterization.
Transrectal ultrasonography (TRUS) and needle biopsy: The choice to proceed with TRUS and biopsy is guided by the PSA level and digital rectal examination. Different algorithms are used to make decisions, such as the following: -patients who, regardless of a digital rectal examination, have a PSA more than 10 ng/ml.
-individuals with free PSA <30% and a PSA of 4–10 ng/ml.
-individuals whose digital rectal examination revealed a palpable nodule.
Gleason score: Two scores are assigned depending on predominant appearance, with a maximum score of 5 + 5 (10). Grading is based on histology from biopsy.
CT/MRI scan: Evaluates lymph node involvement and the degree of local invasion.
For bone metastases, use an isotope bone scan.
TNM staging scheme:
T1: confined to the prostate (a: one lobe; b: both lobes); T3: extending through capsule; T4: fixed tumor invading adjacent structures other than seminal vesicles; N1: regional lymph nodes involved; M: metastases. T1a: incidental <5% on TURP; T1b: incidental >5% on TURP; T1c: identified on needle biopsy.
Screening: In the United States, PSA values and digital rectal examination are employed. There is not enough evidence to support universal screening.
Management
Multidisciplinary discussion: on the best treatment option based on the patient's wishes, age, and comorbidities, as well as tumor staging.
Active monitoring For people with low and intermediate risks, watchful waiting along with PSA monitoring is usually the best course of action.
For tumors restricted to the gland, a radical prostatectomy may be necessary. Retropubic (for pelvic lymph node sample) or perineal approaches can be used for this. through laparoscopic, robotically assisted, or open surgery techniques.
Medical hormone therapy involves starting with an anti-androgen (cyproterone acetate) and LHRH analogues (goserelin, for example) to prevent a testosterone flare-up. Other treatments include anti-androgens, such as steroidal or nonsteroidal forms like flutamide and bicalutamide. is a neoadjuvant treatment option.
Surgery for androgen ablation: A bilateral orchidectomy can impede the course of the illness.
Chemotherapy: Hormone-refractory diseases may be treated with cetaxel.
Adjuvant radiation may be used in cases where the surgical resection margins are insufficient or where tumors that are limited to the pelvis affect lymph nodes. Moreover, brachytherapy is an option. It has been demonstrated that neoadjuvant hormone treatment works well for big but localized tumors before external beam radiation therapy. For the treatment of neurological issues and bone pain, palliative radiation therapy is an option.
Complications
Spread: Most frequently, blood-borne spread affects bone (particularly the spine), lung, and liver. Local growth occurs into seminal vesicles, the bladder, and the rectum. Lymphatic spread travels to the iliac and para-aortic nodes.
From disease: metastatic illness, hypercalcemia, obstructive hydronephrosis.
Following surgery: urethral stricture, impotence, and incontinence.
bladder and bowel damage from radiation.
Androgen shortage can result in libido loss, gynecomastia, hot flashes, impotence, and osteoporosis through hormone therapy. Anti-androgen treatment resistance due to tumour hormone escape.
Prognosis
Radical therapy yields a 10-year survival of more than 80%; untreated patients had an 80% 5-year survival.
The median survival time for metastatic illness is 18–24 months.
Introduction
a primary prostate gland malignant tumor. 95% of the cases are adenocarcinomas, which vary in their level of differentiation.
Risk Factors
The largest risk factor is age. Afro-Caribbean people are more likely than Caucasian people to present with an aggressive disease at a younger age. Geographic distribution: lower in the Far East and higher in North America and Europe. Gene implicated on chromosome 1 in family history. Dietary factors: Consumption of meat, alcohol, and high fat foods is linked to reduced soy intake.
Epidemiology
The second leading cause of cancer-related mortality in men. 50–70 instances per 100,000 year.
80% of males over 80 years old who have autopsies had microfoci related to malignancy.
History
frequently asymptomatic and found through PSA testing.
Obstruction of the lower urinary tract: nocturia, terminal dribbling, weak stream, hesitation, and frequency.
Metastatic spread: Spinal cord compression or discomfort in the bones as a result of metastases.
Anorexia, weight loss, and malaise are common signs of cancer.
Examination
Asymmetrical hard nodular prostate gland with lack of the midline sulcus was seen during a digital rectal examination.
Investigations
Blood: bone profile, PSA, LFT, U&E, and FBC.
Antigen specific to prostates: Age-related and non-specific values may be higher in cases of prostatitis, benign prostatic hyperplasia, or after catheterization.
Transrectal ultrasonography (TRUS) and needle biopsy: The choice to proceed with TRUS and biopsy is guided by the PSA level and digital rectal examination. Different algorithms are used to make decisions, such as the following: -patients who, regardless of a digital rectal examination, have a PSA more than 10 ng/ml.
-individuals with free PSA <30% and a PSA of 4–10 ng/ml.
-individuals whose digital rectal examination revealed a palpable nodule.
Gleason score: Two scores are assigned depending on predominant appearance, with a maximum score of 5 + 5 (10). Grading is based on histology from biopsy.
CT/MRI scan: Evaluates lymph node involvement and the degree of local invasion.
For bone metastases, use an isotope bone scan.
TNM staging scheme:
T1: confined to the prostate (a: one lobe; b: both lobes); T3: extending through capsule; T4: fixed tumor invading adjacent structures other than seminal vesicles; N1: regional lymph nodes involved; M: metastases. T1a: incidental <5% on TURP; T1b: incidental >5% on TURP; T1c: identified on needle biopsy.
Screening: In the United States, PSA values and digital rectal examination are employed. There is not enough evidence to support universal screening.
Management
Multidisciplinary discussion: on the best treatment option based on the patient's wishes, age, and comorbidities, as well as tumor staging.
Active monitoring For people with low and intermediate risks, watchful waiting along with PSA monitoring is usually the best course of action.
For tumors restricted to the gland, a radical prostatectomy may be necessary. Retropubic (for pelvic lymph node sample) or perineal approaches can be used for this. through laparoscopic, robotically assisted, or open surgery techniques.
Medical hormone therapy involves starting with an anti-androgen (cyproterone acetate) and LHRH analogues (goserelin, for example) to prevent a testosterone flare-up. Other treatments include anti-androgens, such as steroidal or nonsteroidal forms like flutamide and bicalutamide. is a neoadjuvant treatment option.
Surgery for androgen ablation: A bilateral orchidectomy can impede the course of the illness.
Chemotherapy: Hormone-refractory diseases may be treated with cetaxel.
Adjuvant radiation may be used in cases where the surgical resection margins are insufficient or where tumors that are limited to the pelvis affect lymph nodes. Moreover, brachytherapy is an option. It has been demonstrated that neoadjuvant hormone treatment works well for big but localized tumors before external beam radiation therapy. For the treatment of neurological issues and bone pain, palliative radiation therapy is an option.
Complications
Spread: Most frequently, blood-borne spread affects bone (particularly the spine), lung, and liver. Local growth occurs into seminal vesicles, the bladder, and the rectum. Lymphatic spread travels to the iliac and para-aortic nodes.
From disease: metastatic illness, hypercalcemia, obstructive hydronephrosis.
Following surgery: urethral stricture, impotence, and incontinence.
bladder and bowel damage from radiation.
Androgen shortage can result in libido loss, gynecomastia, hot flashes, impotence, and osteoporosis through hormone therapy. Anti-androgen treatment resistance due to tumour hormone escape.
Prognosis
Radical therapy yields a 10-year survival of more than 80%; untreated patients had an 80% 5-year survival.
The median survival time for metastatic illness is 18–24 months.
- Published on
Surgery - Renal Carcinoma
Introduction
Malignancy originating from the renal tubular epithelium.
Etiology
Mutations in the oncogene (MET) or tumor suppressor genes (VHL, TSC) are linked to sporadic and hereditary forms.
Von Hippel-Lindau disease, hereditary papillary renal carcinoma, familial renal oncocytoma, and hereditary renal carcinoma are examples of hereditary syndromes.
Risk Factors
Chronic dialysis is used to treat acquired cystic disease of the kidney, obesity, smoking, and tuberous sclerosis.
Epidemiology
Rare (three percent of adult cancer cases). 3:1 male to female. grows with age; in men over 60, 75% of cases occur.
History
90% of the time asymptomatic, accidental discovery made when scanning. the traditional trio of abdominal mass, flank pain, and haematuria (only 10% of patients).
Systemic indications of cancer: Loss of weight, lethargy, and paraneoplastic disorders, such as polycythaemia or hypercalcaemia-related pyrexia, are also present.
Examination
Anaemia, plethora, hypertension, or no symptoms could exist. renal tumor that is palpable.A left-sided varicocoele can result from occlusion of the left testicular vein by a left-sided tumor that extends into the left renal vein. In terms of presentation, one-third had metastases.
Investigations
Urine: Cytology, Dipstick (for haematuria detection).
FBC, U&Es, Ca2+, LFTs (linked to paraneoplastic syndromes such as polycythemia, hypercalcemia, abnormal LFTs in the absence of liver metastases, and Stauffer syndrome), and ESR in 75% of the blood samples.
Imaging: bone and PET scanning for metastases; ultrasound, CT, or MRI scans.
Pathology: Clear cell, chromophilic, chromophobic, oncocytoma, and collecting duct are among the histological forms.
Robson staging : I: tumor inside the renal capsule. II: invades the perinephric fat but not Gerota's fascia . III: Invades local lymph nodes, the IVC, or the renal vein. IV: infiltrates distant metastases or nearby viscera.
Management
Surgery : The usual procedure is a radical nephrectomy, which involves the removal of the ipsilateral adrenal gland, regional lymphadenectomy, Gerota's fascia, and perinephric fat. can be carried out using laparoscopic, thoraco-abdominal, transperitoneal, or flank methods.
Radiation therapy and chemotherapy: Renal Carcinoma is well known for its chemotherapeutic agent resistance, which is mediated by p-glycoprotein, a multidrug resistance protein. With more recent multikinase inhibitors like sunitinib and sorafenib, positive results are achievable. Metastatic lesions may be treated with radiation therapy.
Complications
50% of distant metastases impact the lung, and 33% the bone. Local invasion, such as the blockage of the IVC or the invasion of perinephric fat. Localized bleeding and clot colic. Paraneoplastic Syndrome.
Prognosis
Depending on the tumor's nature and stage. Five-year survival after stage I disease excision is 94%; nodal spread accounts for 18–30% of the survival, whereas distant metastases account for 0–20%.
Introduction
Malignancy originating from the renal tubular epithelium.
Etiology
Mutations in the oncogene (MET) or tumor suppressor genes (VHL, TSC) are linked to sporadic and hereditary forms.
Von Hippel-Lindau disease, hereditary papillary renal carcinoma, familial renal oncocytoma, and hereditary renal carcinoma are examples of hereditary syndromes.
Risk Factors
Chronic dialysis is used to treat acquired cystic disease of the kidney, obesity, smoking, and tuberous sclerosis.
Epidemiology
Rare (three percent of adult cancer cases). 3:1 male to female. grows with age; in men over 60, 75% of cases occur.
History
90% of the time asymptomatic, accidental discovery made when scanning. the traditional trio of abdominal mass, flank pain, and haematuria (only 10% of patients).
Systemic indications of cancer: Loss of weight, lethargy, and paraneoplastic disorders, such as polycythaemia or hypercalcaemia-related pyrexia, are also present.
Examination
Anaemia, plethora, hypertension, or no symptoms could exist. renal tumor that is palpable.A left-sided varicocoele can result from occlusion of the left testicular vein by a left-sided tumor that extends into the left renal vein. In terms of presentation, one-third had metastases.
Investigations
Urine: Cytology, Dipstick (for haematuria detection).
FBC, U&Es, Ca2+, LFTs (linked to paraneoplastic syndromes such as polycythemia, hypercalcemia, abnormal LFTs in the absence of liver metastases, and Stauffer syndrome), and ESR in 75% of the blood samples.
Imaging: bone and PET scanning for metastases; ultrasound, CT, or MRI scans.
Pathology: Clear cell, chromophilic, chromophobic, oncocytoma, and collecting duct are among the histological forms.
Robson staging : I: tumor inside the renal capsule. II: invades the perinephric fat but not Gerota's fascia . III: Invades local lymph nodes, the IVC, or the renal vein. IV: infiltrates distant metastases or nearby viscera.
Management
Surgery : The usual procedure is a radical nephrectomy, which involves the removal of the ipsilateral adrenal gland, regional lymphadenectomy, Gerota's fascia, and perinephric fat. can be carried out using laparoscopic, thoraco-abdominal, transperitoneal, or flank methods.
Radiation therapy and chemotherapy: Renal Carcinoma is well known for its chemotherapeutic agent resistance, which is mediated by p-glycoprotein, a multidrug resistance protein. With more recent multikinase inhibitors like sunitinib and sorafenib, positive results are achievable. Metastatic lesions may be treated with radiation therapy.
Complications
50% of distant metastases impact the lung, and 33% the bone. Local invasion, such as the blockage of the IVC or the invasion of perinephric fat. Localized bleeding and clot colic. Paraneoplastic Syndrome.
Prognosis
Depending on the tumor's nature and stage. Five-year survival after stage I disease excision is 94%; nodal spread accounts for 18–30% of the survival, whereas distant metastases account for 0–20%.
- Published on
Surgery - Testicular Cancer
Definition
cancer that starts in the testes.
Risk Factors
Risk of ectopic testis or testicular maldescent increased 40 times. Other factors include exposure to maternal oestrogen, family history, mumps, and contralateral testicular tumor. KIT gene mutations and chromosome 12 amplifications and deletions are among the genetic alterations discovered.
Epidemiology
Less prevalent, accounting for 1% of cancer cases in men, but more common in those aged 18 to 35, with a trimodal peak incidence in infancy, 25 to 40 years, and 60 years. Caucasians are more at risk than people of Asian or African descent.
History
A lump found in the testicles. Back pain from para-aortic lymphadenopathy, dyspnea, coughing, or hemoptysis from lung metastases are uncommon causes of back pain.
Examination
Hard testicular tumor that is painless; a secondary hydrocoele may be present. Lymphadenopathy (para-aortic, supraclavicular, etc.). Pleural effusion symptoms. Gynecomastia (caused by the production of HCG).
Pathogenesis
Seminomas (40 percent, peak in 30–40 years) and nonseminomatous germ-cell tumors (60 percent, peak in 20–30 years) are the two types of germ cell tumors. Embyronal cell carcinoma, choriocarcinoma, yolk sac tumors, and teratomas are examples of seminomas. Sertoli and Leydig cell tumors, as well as non-Hodgkin's lymphoma, are less common non-germ cell tumors. Seminomas are solid, light-colored, and well confined. Teratomas have a cystic appearance with parts that are necrotic and hemorrhagic.
Micro: Seminomas are made up of sheets of homogeneous, densely packed cells that can range from anaplastic to well-differentiated spermatocytes. Teratomas are categorized according to the relative proportions and may comprise elements of embryonal and trophoblastic cell types with varied levels of development, as well as tissue from the yolk sac.
Investigations
Blood: FBC, Tumor Markers, U&Es, LFTs LDH, a-fetoprotein, and b-HCG.
Pee: Pregnancy test: If the tumor generates b-HCG, the test is positive.
Ultrasound of the testicles: To see the main tumor.
CT scan for staging (abdomen, chest, and brain if disease is widespread). MRI for unclear lesions or FDG-PET for any remaining seminoma masses.
Either Royal Marsden Hospital staging or TNM staging is employed.
I - Excluded from testes.
II: Lymphadenopathy of the abdomen; A: <2 cm, B: 2–5 cm, C: >5 cm.
III: Nodal involvement above diaphragm; A, B, and C as mentioned previously.
Extralymphatic metastases (Part IV).
Management
depends on the tumor's prognostic classification, stage, and histology. Before receiving chemotherapy or radiation therapy, patients should be given sperm banking.
Seminoma: Excision of the afflicted testis with radical inguinal orchidectomy.
Stage I: Adjuvant radiation (seminomas are very radiosensitive), chemotherapy (one carboplatin cycle), or observation are the available options.
Radiotherapy, chemotherapy, or both in stages IIA and IIB.
Multiagent chemotherapy (e.g., BEP; bleomycin, etoposide, cisplatin) for patients in Stage IIC and above.
Radical inguinal orchidectomy in nonseminomatous GCT.
Microscopic metastases to retroperitoneal lymph nodes will occur in 30% of cases in stage I. Options include primary retroperitoneal lymph node dissection (RPLND), chemotherapy, and surveillance.
Stage II–IV: RPLND and/or multiagent platinum-based chemotherapy (seedling retroperitoneal lymph node masses that are less than 1 cm in size should be excised since they might harbor residual tumor material).
Complications
Of the illness: Metastases leading to neurological or pulmonary issues.
Treatment: Surgery for hemorrhage, nerve damage, and wound infection.
Chemotherapy side effects include bone marrow depression, nausea, and vomiting. While platinum compounds are neuro- and nephrotoxic, bleomycin can result in rashes, pneumonitis, or fibrosis. heart illness and subsequent cancers with long-term survival.
Blood-borne spread to the lungs, brain, bone, and liver; local spread to the tunica vaginalis and down the spermatic cord; lymphatic spread to the para-aortic nodes, then to the mediastinal and supraclavicular nodes.
Prognosis
Good, with 90%–100% cure rates for early-stage illnesses. Seminomas have a high rate of cure.
The prognosis for choriocarcinomas is the worst.
Definition
cancer that starts in the testes.
Risk Factors
Risk of ectopic testis or testicular maldescent increased 40 times. Other factors include exposure to maternal oestrogen, family history, mumps, and contralateral testicular tumor. KIT gene mutations and chromosome 12 amplifications and deletions are among the genetic alterations discovered.
Epidemiology
Less prevalent, accounting for 1% of cancer cases in men, but more common in those aged 18 to 35, with a trimodal peak incidence in infancy, 25 to 40 years, and 60 years. Caucasians are more at risk than people of Asian or African descent.
History
A lump found in the testicles. Back pain from para-aortic lymphadenopathy, dyspnea, coughing, or hemoptysis from lung metastases are uncommon causes of back pain.
Examination
Hard testicular tumor that is painless; a secondary hydrocoele may be present. Lymphadenopathy (para-aortic, supraclavicular, etc.). Pleural effusion symptoms. Gynecomastia (caused by the production of HCG).
Pathogenesis
Seminomas (40 percent, peak in 30–40 years) and nonseminomatous germ-cell tumors (60 percent, peak in 20–30 years) are the two types of germ cell tumors. Embyronal cell carcinoma, choriocarcinoma, yolk sac tumors, and teratomas are examples of seminomas. Sertoli and Leydig cell tumors, as well as non-Hodgkin's lymphoma, are less common non-germ cell tumors. Seminomas are solid, light-colored, and well confined. Teratomas have a cystic appearance with parts that are necrotic and hemorrhagic.
Micro: Seminomas are made up of sheets of homogeneous, densely packed cells that can range from anaplastic to well-differentiated spermatocytes. Teratomas are categorized according to the relative proportions and may comprise elements of embryonal and trophoblastic cell types with varied levels of development, as well as tissue from the yolk sac.
Investigations
Blood: FBC, Tumor Markers, U&Es, LFTs LDH, a-fetoprotein, and b-HCG.
Pee: Pregnancy test: If the tumor generates b-HCG, the test is positive.
Ultrasound of the testicles: To see the main tumor.
CT scan for staging (abdomen, chest, and brain if disease is widespread). MRI for unclear lesions or FDG-PET for any remaining seminoma masses.
Either Royal Marsden Hospital staging or TNM staging is employed.
I - Excluded from testes.
II: Lymphadenopathy of the abdomen; A: <2 cm, B: 2–5 cm, C: >5 cm.
III: Nodal involvement above diaphragm; A, B, and C as mentioned previously.
Extralymphatic metastases (Part IV).
Management
depends on the tumor's prognostic classification, stage, and histology. Before receiving chemotherapy or radiation therapy, patients should be given sperm banking.
Seminoma: Excision of the afflicted testis with radical inguinal orchidectomy.
Stage I: Adjuvant radiation (seminomas are very radiosensitive), chemotherapy (one carboplatin cycle), or observation are the available options.
Radiotherapy, chemotherapy, or both in stages IIA and IIB.
Multiagent chemotherapy (e.g., BEP; bleomycin, etoposide, cisplatin) for patients in Stage IIC and above.
Radical inguinal orchidectomy in nonseminomatous GCT.
Microscopic metastases to retroperitoneal lymph nodes will occur in 30% of cases in stage I. Options include primary retroperitoneal lymph node dissection (RPLND), chemotherapy, and surveillance.
Stage II–IV: RPLND and/or multiagent platinum-based chemotherapy (seedling retroperitoneal lymph node masses that are less than 1 cm in size should be excised since they might harbor residual tumor material).
Complications
Of the illness: Metastases leading to neurological or pulmonary issues.
Treatment: Surgery for hemorrhage, nerve damage, and wound infection.
Chemotherapy side effects include bone marrow depression, nausea, and vomiting. While platinum compounds are neuro- and nephrotoxic, bleomycin can result in rashes, pneumonitis, or fibrosis. heart illness and subsequent cancers with long-term survival.
Blood-borne spread to the lungs, brain, bone, and liver; local spread to the tunica vaginalis and down the spermatic cord; lymphatic spread to the para-aortic nodes, then to the mediastinal and supraclavicular nodes.
Prognosis
Good, with 90%–100% cure rates for early-stage illnesses. Seminomas have a high rate of cure.
The prognosis for choriocarcinomas is the worst.
- Published on
Surgery - Testicular Torsion
Definition
An urgent surgical procedure is required to treat spermatic cord twisting or torsion, which first obstructs the testis's venous outflow and, if left untreated, progresses to artery occlusion and testicular infarction.
Etiology
Intravaginal (most common type): The testis might twist inside the vaginalis due to a large investment of the tunica vaginalis around the spermatic cord.
Extravaginal (found in newborns): A condition in which the spermatic cord twists along a vertical axis, causing the entire testes and tunica vaginalis to twist (since the gubernaculum is not fully fixed to the scrotal wall, allowing for unrestricted rotation).
Risk Factors
Bell clapper testes, or imperfectly descending testes, have a large investment in the tunica vaginalis, and the epididymal mesentery is lengthy.
Epidemiology
Incidence each year: 1 in 4000. The most frequent cause of acute scrotal pain in children aged 10 to 18 is intravaginal. exceptionally uncommon in newborns (extravaginal torsion).
H HISTORY
strong hemiscrotal pain that develops suddenly and may be accompanied by nausea, vomiting, and stomach pain. The patient may have discomfort upon awakening from sleep or may have previously experienced a similar pain that resolved on its own.
Examination
The affected side may have an erythematous, swollen scrotum, a palpably thicker cord, and an anteriorly positioned epididymis. The testis may be extremely tender, positioned higher than the contralateral side, and horizontal. There might not be a cremasteric response.
Differential diagnosis: Appendix testes, appendix epididymis, and hydatid of Morgagni are examples of testicular appendix torsion. A lesion that is apparent via transillumination (blue dot sign) might exist.
Epididymo-orchitis with inguinal hernia in prison.
Pathogenesis
If the blood supply is not restored by detorsion, twisting causes compression of the veins of the pampiniform plexus from the testis and venous congestion, which leads to progressive ischaemia and infarction.
Investigational studies
Until proven otherwise, a young boy or adolescent with a very sensitive and swollen testis should be treated as if they have torsion, necessitating immediate investigation.
Testicular Doppler or Duplex Imaging: Surgery shouldn't be postponed, but it may be done.
In cases of torsion, arterial inflow may be decreased; in cases of epididymo-orchitis, it may cease.
Management
Surgical: Scrotal exploration should ideally be done within six hours of the onset of symptoms.
Counseling on bilateral orchidopexy and orchidectomy should be a part of consent. A transverse or midline raphe incision is done through the muscle of the dartos. The testis is delivered and examined after the tunica vaginalis is opened. The testis is untwisted, allowed to reperfuse, and then covered for a short while with a warm swab soaked in saline.
Bilateral orchidopexy is performed next. In order to stop recurrence, the testis was traditionally fixed in three places to the scrotal tissues using nonabsorbable sutures. An orchidectomy is carried out if it is discovered that the testis is necrotic.
Complications
Atrophy and infarction of the testicles if treatment is delayed. If left untreated, the testes could become infected or worsen fertility by encouraging the production of antibodies against sperm.
hemorrhage and infection following surgery.
Prognosis
A testicular torsion may only last 4-6 hours from the time pain starts.Most instances can be saved with quick investigation.
Definition
An urgent surgical procedure is required to treat spermatic cord twisting or torsion, which first obstructs the testis's venous outflow and, if left untreated, progresses to artery occlusion and testicular infarction.
Etiology
Intravaginal (most common type): The testis might twist inside the vaginalis due to a large investment of the tunica vaginalis around the spermatic cord.
Extravaginal (found in newborns): A condition in which the spermatic cord twists along a vertical axis, causing the entire testes and tunica vaginalis to twist (since the gubernaculum is not fully fixed to the scrotal wall, allowing for unrestricted rotation).
Risk Factors
Bell clapper testes, or imperfectly descending testes, have a large investment in the tunica vaginalis, and the epididymal mesentery is lengthy.
Epidemiology
Incidence each year: 1 in 4000. The most frequent cause of acute scrotal pain in children aged 10 to 18 is intravaginal. exceptionally uncommon in newborns (extravaginal torsion).
H HISTORY
strong hemiscrotal pain that develops suddenly and may be accompanied by nausea, vomiting, and stomach pain. The patient may have discomfort upon awakening from sleep or may have previously experienced a similar pain that resolved on its own.
Examination
The affected side may have an erythematous, swollen scrotum, a palpably thicker cord, and an anteriorly positioned epididymis. The testis may be extremely tender, positioned higher than the contralateral side, and horizontal. There might not be a cremasteric response.
Differential diagnosis: Appendix testes, appendix epididymis, and hydatid of Morgagni are examples of testicular appendix torsion. A lesion that is apparent via transillumination (blue dot sign) might exist.
Epididymo-orchitis with inguinal hernia in prison.
Pathogenesis
If the blood supply is not restored by detorsion, twisting causes compression of the veins of the pampiniform plexus from the testis and venous congestion, which leads to progressive ischaemia and infarction.
Investigational studies
Until proven otherwise, a young boy or adolescent with a very sensitive and swollen testis should be treated as if they have torsion, necessitating immediate investigation.
Testicular Doppler or Duplex Imaging: Surgery shouldn't be postponed, but it may be done.
In cases of torsion, arterial inflow may be decreased; in cases of epididymo-orchitis, it may cease.
Management
Surgical: Scrotal exploration should ideally be done within six hours of the onset of symptoms.
Counseling on bilateral orchidopexy and orchidectomy should be a part of consent. A transverse or midline raphe incision is done through the muscle of the dartos. The testis is delivered and examined after the tunica vaginalis is opened. The testis is untwisted, allowed to reperfuse, and then covered for a short while with a warm swab soaked in saline.
Bilateral orchidopexy is performed next. In order to stop recurrence, the testis was traditionally fixed in three places to the scrotal tissues using nonabsorbable sutures. An orchidectomy is carried out if it is discovered that the testis is necrotic.
Complications
Atrophy and infarction of the testicles if treatment is delayed. If left untreated, the testes could become infected or worsen fertility by encouraging the production of antibodies against sperm.
hemorrhage and infection following surgery.
Prognosis
A testicular torsion may only last 4-6 hours from the time pain starts.Most instances can be saved with quick investigation.